Insider Trades98 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Sell | PTCT | Pierre Gravier | CHIEF FINANCIAL OFFICER | 3,494 | $80.35 | $6.5B | -13.51% | +82.03% | $280.7K | -3.99% | — | Buy Now |
| Jul 9, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 4,928 | $68.39 | $6.5B | -13.51% | +82.03% | $337.1K | +0.00% | 10b5-1 | Buy Now |
| Jul 6, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 10,158 | $64.22 | $6.5B | -13.51% | +82.03% | $652.4K | +0.00% | 10b5-1 | Buy Now |
| Jul 6, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 93,548 | $63.19 | $6.5B | -13.51% | +82.03% | $5.9M | +0.00% | 10b5-1 | Buy Now |
| Jun 26, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 16,260 | $61.68 | $6.5B | -13.51% | +82.03% | $1.0M | +0.00% | 10b5-1 | Buy Now |
| Jun 24, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 52,566 | $61.94 | $6.5B | -13.51% | +82.03% | $3.3M | +0.00% | 10b5-1 | Buy Now |
| Jun 22, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 47,498 | $53.30 | $6.5B | -13.51% | +82.03% | $2.5M | +0.00% | 10b5-1 | Buy Now |
| Jun 17, 2026 | Buy | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 20,984 | $62.55 | $6.5B | -13.51% | +82.03% | $1.3M | +0.01% | 10b5-1 | Buy Now |
| Jun 17, 2026 | Sell | PTCT | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 39,372 | $50.63 | $6.5B | -13.51% | +82.03% | $2.0M | +0.00% | 10b5-1 | Buy Now |
| Jun 10, 2026 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 38,843 | $49.23 | $6.5B | -13.51% | +82.03% | $1.9M | -1.54% | 10b5-1 | Buy Now |
| May 15, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 5,624 | $48.93 | $6.5B | -13.51% | +82.03% | $275.2K | +0.00% | 10b5-1 | Buy Now |
| May 14, 2026 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 12,572 | $72.95 | $6.5B | -13.51% | +82.03% | $917.2K | -0.78% | — | Buy Now |
| May 8, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 7,080 | $62.76 | $6.5B | -13.51% | +82.03% | $444.3K | +0.00% | 10b5-1 | Buy Now |
| Apr 21, 2026 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 2,850 | $70.91 | $6.5B | -13.51% | +82.03% | $202.1K | -0.72% | — | Buy Now |
| Apr 6, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 4,530 | $54.43 | $6.5B | -13.51% | +82.03% | $246.6K | +0.00% | 10b5-1 | Buy Now |
| Apr 2, 2026 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 829 | $67.99 | $6.5B | -13.51% | +82.03% | $56.4K | -1.04% | — | Buy Now |
| Apr 1, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 52,003 | $69.04 | $6.5B | -13.51% | +82.03% | $3.6M | -21.22% | 10b5-1 | Buy Now |
| Mar 12, 2026 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 2,662 | $64.08 | $6.5B | -13.51% | +82.03% | $170.6K | -0.67% | — | Buy Now |
| Mar 5, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 3,989 | $63.38 | $6.5B | -13.51% | +82.03% | $252.8K | -59.31% | 10b5-1 | Buy Now |
| Mar 5, 2026 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 10,000 | $63.38 | $6.5B | -13.51% | +82.03% | $633.8K | -11.12% | 10b5-1 | Buy Now |
| Feb 19, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 3,019 | $69.48 | $6.5B | -13.51% | +82.03% | $209.8K | -0.71% | 10b5-1 | Buy Now |
| Feb 18, 2026 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 2,484 | $69.36 | $6.5B | -13.51% | +82.03% | $172.3K | -2.69% | — | Buy Now |
| Feb 18, 2026 | Sell | PTCT | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 2,494 | $69.36 | $6.5B | -13.51% | +82.03% | $173.0K | -3.43% | — | Buy Now |
| Feb 18, 2026 | Sell | PTCT | Pierre Gravier | CHIEF FINANCIAL OFFICER | 2,992 | $69.36 | $6.5B | -13.51% | +82.03% | $207.5K | -3.31% | — | Buy Now |
| Feb 18, 2026 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 3,019 | $69.36 | $6.5B | -13.51% | +82.03% | $209.4K | -3.77% | — | Buy Now |
| Feb 18, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 3,121 | $69.36 | $6.5B | -13.51% | +82.03% | $216.5K | -2.56% | — | Buy Now |
| Feb 18, 2026 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 7,371 | $69.36 | $6.5B | -13.51% | +82.03% | $511.3K | -1.87% | — | Buy Now |
| Feb 17, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 8,707 | $55.23 | $6.5B | -13.51% | +82.03% | $480.9K | -0.65% | 10b5-1 | Buy Now |
| Jan 8, 2026 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 866 | $76.45 | $6.5B | -13.51% | +82.03% | $66.2K | -0.93% | — | Buy Now |
| Jan 8, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 940 | $76.45 | $6.5B | -13.51% | +82.03% | $71.9K | -0.76% | — | Buy Now |
| Jan 8, 2026 | Sell | PTCT | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 1,034 | $76.45 | $6.5B | -13.51% | +82.03% | $79.0K | -1.40% | — | Buy Now |
| Jan 8, 2026 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 2,514 | $76.45 | $6.5B | -13.51% | +82.03% | $192.2K | -0.63% | — | Buy Now |
| Jan 8, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 6,347 | $77.06 | $6.5B | -13.51% | +82.03% | $489.1K | -0.93% | 10b5-1 | Buy Now |
| Jan 8, 2026 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 7,348 | $77.02 | $6.5B | -13.51% | +82.03% | $565.9K | -1.75% | 10b5-1 | Buy Now |
| Jan 6, 2026 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 1,982 | $77.12 | $6.5B | -13.51% | +82.03% | $152.9K | -1.05% | — | Buy Now |
| Jan 6, 2026 | Sell | PTCT | Pierre Gravier | CHIEF FINANCIAL OFFICER | 2,139 | $76.95 | $6.5B | -13.51% | +82.03% | $164.6K | -2.31% | — | Buy Now |
| Jan 6, 2026 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 2,411 | $77.19 | $6.5B | -13.51% | +82.03% | $186.1K | -0.97% | — | Buy Now |
| Jan 6, 2026 | Sell | PTCT | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 2,616 | $77.19 | $6.5B | -13.51% | +82.03% | $201.9K | -1.73% | — | Buy Now |
| Jan 6, 2026 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 3,141 | $77.18 | $6.5B | -13.51% | +82.03% | $242.4K | -1.75% | — | Buy Now |
| Jan 6, 2026 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 8,165 | $77.15 | $6.5B | -13.51% | +82.03% | $629.9K | -1.01% | — | Buy Now |
| Jan 6, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 9,994 | $64.07 | $6.5B | -13.51% | +82.03% | $640.3K | -0.27% | 10b5-1 | Buy Now |
| Jan 5, 2026 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 4,532 | $57.48 | $6.5B | -13.51% | +82.03% | $260.5K | +0.00% | 10b5-1 | Buy Now |
| Dec 30, 2025 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 8,089 | $76.64 | $6.5B | -13.51% | +82.03% | $619.9K | -2.31% | — | Buy Now |
| Dec 19, 2025 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 41,016 | $71.20 | $6.5B | -13.51% | +82.03% | $2.9M | +0.00% | 10b5-1 | Buy Now |
| Dec 17, 2025 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 86,984 | $68.75 | $6.5B | -13.51% | +82.03% | $6.0M | +0.00% | 10b5-1 | Buy Now |
| Dec 2, 2025 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 3,428 | $79.07 | $6.5B | -13.51% | +82.03% | $271.1K | -0.97% | — | Buy Now |
| Nov 25, 2025 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 143,856 | $57.10 | $6.5B | -13.51% | +82.03% | $8.2M | +0.00% | 10b5-1 | Buy Now |
| Nov 24, 2025 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 71,144 | $55.20 | $6.5B | -13.51% | +82.03% | $3.9M | +0.00% | 10b5-1 | Buy Now |
| Nov 17, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 5,624 | $50.84 | $6.5B | -13.51% | +82.03% | $285.9K | +0.00% | 10b5-1 | Buy Now |
| Oct 7, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 6,750 | $50.77 | $6.5B | -13.51% | +82.03% | $342.7K | +0.00% | 10b5-1 | Buy Now |
| Oct 3, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 49,842 | $52.58 | $6.5B | -13.51% | +82.03% | $2.6M | +0.00% | 10b5-1 | Buy Now |
| Oct 3, 2025 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 110,000 | $48.46 | $6.5B | -13.51% | +82.03% | $5.3M | +0.00% | 10b5-1 | Buy Now |
| Sep 11, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 94,498 | $49.64 | $6.5B | -13.51% | +82.03% | $4.7M | +0.00% | 10b5-1 | Buy Now |
| Sep 8, 2025 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 79,700 | $39.83 | $6.5B | -13.51% | +82.03% | $3.2M | +0.00% | 10b5-1 | Buy Now |
| Aug 15, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 5,626 | $37.14 | $6.5B | -13.51% | +82.03% | $208.9K | +0.00% | 10b5-1 | Buy Now |
| Aug 5, 2025 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 10,739 | $51.74 | $6.5B | -13.51% | +82.03% | $555.6K | -3.08% | — | Buy Now |
| Jul 15, 2025 | Sell | PTCT | Pierre Gravier | CHIEF FINANCIAL OFFICER | 2,516 | $49.46 | $6.5B | -13.51% | +82.03% | $124.4K | -3.38% | — | Buy Now |
| May 15, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 5,624 | $35.91 | $6.5B | -13.51% | +82.03% | $202.0K | +0.00% | 10b5-1 | Buy Now |
| Apr 22, 2025 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 2,804 | $48.74 | $6.5B | -13.51% | +82.03% | $136.7K | -1.02% | — | Buy Now |
| Apr 2, 2025 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 897 | $46.95 | $6.5B | -13.51% | +82.03% | $42.1K | -1.17% | — | Buy Now |
| Mar 14, 2025 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 11,220 | $56.16 | $6.5B | -13.51% | +82.03% | $630.1K | -2.88% | 10b5-1 | Buy Now |
| Mar 12, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 31,042 | $43.16 | $6.5B | -13.51% | +82.03% | $1.3M | +0.00% | 10b5-1 | Buy Now |
| Mar 10, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 150,840 | $42.50 | $6.5B | -13.51% | +82.03% | $6.4M | +0.00% | 10b5-1 | Buy Now |
| Feb 19, 2025 | Sell | PTCT | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 1,757 | $50.11 | $6.5B | -13.51% | +82.03% | $88.0K | -1.38% | — | Buy Now |
| Feb 19, 2025 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 1,757 | $50.11 | $6.5B | -13.51% | +82.03% | $88.0K | -1.12% | — | Buy Now |
| Feb 19, 2025 | Sell | PTCT | Pierre Gravier | CHIEF FINANCIAL OFFICER | 2,335 | $50.11 | $6.5B | -13.51% | +82.03% | $117.0K | -1.53% | — | Buy Now |
| Feb 19, 2025 | Sell | PTCT | Eric Pauwels | CHIEF EXECUTIVE OFFICER | 2,945 | $50.11 | $6.5B | -13.51% | +82.03% | $147.6K | -1.71% | — | Buy Now |
| Feb 19, 2025 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 2,946 | $50.11 | $6.5B | -13.51% | +82.03% | $147.6K | -1.36% | — | Buy Now |
| Feb 19, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 2,947 | $50.11 | $6.5B | -13.51% | +82.03% | $147.7K | -1.39% | — | Buy Now |
| Feb 19, 2025 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 7,792 | $50.11 | $6.5B | -13.51% | +82.03% | $390.5K | -1.38% | — | Buy Now |
| Jan 7, 2025 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 2,008 | $44.84 | $6.5B | -13.51% | +82.03% | $90.0K | -1.25% | — | Buy Now |
| Jan 7, 2025 | Sell | PTCT | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 2,953 | $44.87 | $6.5B | -13.51% | +82.03% | $132.5K | -2.22% | — | Buy Now |
| Jan 7, 2025 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 2,979 | $44.87 | $6.5B | -13.51% | +82.03% | $133.7K | -1.34% | — | Buy Now |
| Jan 7, 2025 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 3,541 | $44.87 | $6.5B | -13.51% | +82.03% | $158.9K | -1.62% | — | Buy Now |
| Jan 7, 2025 | Sell | PTCT | Eric Pauwels | CHIEF EXECUTIVE OFFICER | 3,735 | $44.86 | $6.5B | -13.51% | +82.03% | $167.6K | -2.08% | — | Buy Now |
| Jan 7, 2025 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 4,544 | $44.90 | $6.5B | -13.51% | +82.03% | $204.0K | -0.79% | — | Buy Now |
| Dec 31, 2024 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 8,279 | $45.16 | $6.5B | -13.51% | +82.03% | $373.9K | -3.67% | — | Buy Now |
| Dec 2, 2024 | Sell | PTCT | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 35,600 | $51.39 | $6.5B | -13.51% | +82.03% | $1.8M | +0.00% | 10b5-1 | Buy Now |
| Dec 2, 2024 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 143,220 | $51.53 | $6.5B | -13.51% | +82.03% | $7.4M | +0.00% | 10b5-1 | Buy Now |
| Dec 2, 2024 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 191,816 | $50.72 | $6.5B | -13.51% | +82.03% | $9.7M | +0.00% | 10b5-1 | Buy Now |
| Jul 16, 2024 | Sell | PTCT | Pierre Gravier | CHIEF FINANCIAL OFFICER | 2,269 | $34.02 | $6.5B | -13.51% | +82.03% | $77.2K | -4.07% | — | Buy Now |
| May 7, 2024 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 175 | $32.82 | $6.5B | -13.51% | +82.03% | $5.7K | -0.29% | — | Buy Now |
| Apr 19, 2024 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 3,361 | $24.89 | $6.5B | -13.51% | +82.03% | $83.7K | -1.47% | — | Buy Now |
| Apr 17, 2024 | Sell | PTCT | Eric Pauwels | CHIEF EXECUTIVE OFFICER | 787 | $25.14 | $6.5B | -13.51% | +82.03% | $19.8K | -1.15% | — | Buy Now |
| Apr 17, 2024 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 1,307 | $25.13 | $6.5B | -13.51% | +82.03% | $32.9K | -0.57% | — | Buy Now |
| Apr 2, 2024 | Sell | PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 526 | $28.37 | $6.5B | -13.51% | +82.03% | $14.9K | -0.87% | — | Buy Now |
| Jan 30, 2024 | Sell | PTCT | Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 318 | $27.25 | $6.5B | -13.51% | +82.03% | $8.7K | -0.89% | — | Buy Now |
| Jan 30, 2024 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 366 | $27.25 | $6.5B | -13.51% | +82.03% | $10.0K | -0.82% | — | Buy Now |
| Jan 30, 2024 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 646 | $27.25 | $6.5B | -13.51% | +82.03% | $17.6K | -0.99% | — | Buy Now |
| Jan 30, 2024 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 794 | $27.25 | $6.5B | -13.51% | +82.03% | $21.6K | -1.10% | — | Buy Now |
| Jan 8, 2024 | Sell | PTCT | Lee Scott Golden | CHIEF MEDICAL OFFICER | 2,000 | $28.87 | $6.5B | -13.51% | +82.03% | $57.7K | -2.53% | — | Buy Now |
| Jan 8, 2024 | Sell | PTCT | Christine Marie Utter | SVP, FINANCE & CAO | 2,841 | $28.86 | $6.5B | -13.51% | +82.03% | $82.0K | -3.73% | — | Buy Now |
| Jan 8, 2024 | Sell | PTCT | Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 2,910 | $28.85 | $6.5B | -13.51% | +82.03% | $84.0K | -2.15% | — | Buy Now |
| Jan 8, 2024 | Sell | PTCT | Mark Elliott Boulding | EXEC. VP AND CLO | 3,395 | $28.85 | $6.5B | -13.51% | +82.03% | $98.0K | -2.27% | — | Buy Now |
| Jan 8, 2024 | Sell | PTCT | Eric Pauwels | CHIEF BUSINESS OFFICER | 3,634 | $28.85 | $6.5B | -13.51% | +82.03% | $104.9K | -3.83% | — | Buy Now |
| Jan 8, 2024 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 7,680 | $28.91 | $6.5B | -13.51% | +82.03% | $222.0K | -2.30% | — | Buy Now |
| Jan 5, 2024 | Sell | PTCT | Matthew B. Klein | CHIEF EXECUTIVE OFFICER | 10,107 | $27.15 | $6.5B | -13.51% | +82.03% | $274.4K | -5.67% | — | Buy Now |
| Dec 12, 2023 | Buy | PTCT | Pierre Gravier | CHIEF FINANCIAL OFFICER | 7,700 | $25.81 | $6.5B | -13.51% | +82.03% | $198.7K | +29.62% | — | Buy Now |